IRIS
JAFFRAIN, MARIE LISE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.475
EU - Europa 3.288
AS - Asia 2.845
SA - Sud America 297
Continente sconosciuto - Info sul continente non disponibili 134
AF - Africa 51
OC - Oceania 12
Totale 13.102
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.235
SG - Singapore 1.139
IT - Italia 767
IE - Irlanda 662
CN - Cina 617
RU - Federazione Russa 563
TR - Turchia 320
SE - Svezia 306
VN - Vietnam 295
HK - Hong Kong 272
DE - Germania 251
BR - Brasile 246
GB - Regno Unito 215
UA - Ucraina 179
FR - Francia 134
CA - Canada 127
FI - Finlandia 102
BD - Bangladesh 32
IN - India 27
JP - Giappone 26
BE - Belgio 22
ES - Italia 20
MX - Messico 20
IL - Israele 19
NL - Olanda 16
CZ - Repubblica Ceca 14
IQ - Iraq 14
AR - Argentina 13
CR - Costa Rica 13
SV - El Salvador 13
PR - Porto Rico 12
VE - Venezuela 12
GP - Guadalupe 11
GT - Guatemala 11
HN - Honduras 11
SC - Seychelles 11
AU - Australia 10
TT - Trinidad e Tobago 10
DZ - Algeria 9
ID - Indonesia 9
KR - Corea 9
PK - Pakistan 9
SA - Arabia Saudita 9
ZA - Sudafrica 8
CW - ???statistics.table.value.countryCode.CW??? 7
EU - Europa 7
KZ - Kazakistan 7
MA - Marocco 7
EC - Ecuador 6
PL - Polonia 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
CO - Colombia 5
LT - Lituania 5
NP - Nepal 5
PY - Paraguay 5
UY - Uruguay 5
KE - Kenya 4
NI - Nicaragua 4
AL - Albania 3
EE - Estonia 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
PT - Portogallo 3
UZ - Uzbekistan 3
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
KH - Cambogia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BZ - Belize 1
CL - Cile 1
CY - Cipro 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
Totale 12.975
Salva come PNG Salva come JPEG
Città #
Jacksonville 703
Chandler 682
Singapore 681
Dublin 662
San Jose 634
Ashburn 469
Dallas 395
Council Bluffs 392
Santa Clara 276
Boardman 268
Hong Kong 268
The Dalles 160
Izmir 148
New York 142
Milan 127
Nanjing 124
San Mateo 124
L’Aquila 114
Moscow 109
Wilmington 103
Princeton 99
Lawrence 98
Ho Chi Minh City 84
Ann Arbor 80
Lauterbourg 72
Beijing 61
Hanoi 60
Los Angeles 53
Dong Ket 48
Rome 41
Des Moines 40
Nanchang 39
Hefei 38
São Paulo 36
Woodbridge 34
Dearborn 33
Verona 31
Naples 30
Shenyang 30
L'aquila 29
Munich 29
Brooklyn 27
Hebei 27
Toronto 27
San Francisco 26
Mountain View 25
Seattle 25
Jiaxing 24
Tokyo 24
Kunming 23
Tianjin 22
Brussels 20
Frankfurt am Main 20
Miano 20
Columbus 19
Helsinki 18
Montreal 18
Orem 18
Guangzhou 17
Atlanta 16
Bologna 16
Shanghai 14
Changsha 13
Jinan 13
Turin 13
Phoenix 12
Florence 11
London 11
Brno 10
Houston 10
Mexico City 10
Ningbo 10
North Bergen 10
San Salvador 10
Bari 9
Buffalo 9
Charlotte 9
Denver 9
Norwalk 9
Palermo 9
Philadelphia 9
Falkenstein 8
Falls Church 8
Genoa 8
Haiphong 8
Pune 8
San Juan 8
Stockholm 8
Zhengzhou 8
Biên Hòa 7
Caracas 7
Da Nang 7
Newark 7
Northridge 7
Queens 7
Rio de Janeiro 7
San José 7
Willemstad 7
Baghdad 6
Changchun 6
Totale 8.427
Salva come PNG Salva come JPEG
Nome #
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up. 199
18F-DOPA PET/CT Physiological Distribution and Pitfalls: Experience in 215 Patients 192
The R304X mutation of the Aryl hydrocarbon receptor Interacting Protein (AIP) gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? 183
L'acromégalie familiale: A propos d'une observation, revue de la littérature 176
X-linked acrogigantism syndrome: Clinical profile and therapeutic responses 176
p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumors 164
Le forme familiari di adenoma ipofisario 156
15 year-old boy with ocular palsy and headache. Invasive macroprolactinoma 151
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly 151
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. 144
Clinical and genetic characterization of pituitary gigantism: An international collaborative study in 208 patients 144
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 143
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pitutuitary adenomas: pathological and clinical implications 142
Contenuto dei grassi nella dieta e rischio di insorgenza di carcinoma della mammella. 138
Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells 138
Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor response. 137
Hypophysitis and Granulomatous Pituitary Lesions in Systemic Diseases 136
Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas 135
Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors 135
How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020 135
Two familial giant pituitary adenomas associated with overweight: clinical, morphological and genetic features 133
From resistant to aggressive and malignant prolactinomas: a translational approach 133
Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art 130
Aggressive prolactinoma in a child related to germline mutation in the Aryl hydrocarbon receptor Interacting Protein (AIP) gene. 130
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 130
Hypophysitis 130
Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly 129
Hyperplasia-adenoma sequence in pituitary tumorigenesis related to Aryl hydrocarbon receptor Interacting Protein gene mutation. 129
Clinical characterization of familial isolated pituitary adenomas 128
Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families 127
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy inpatients with prolactin-secreting pituitary adenomas 126
HMGA1-pseudogene expression is induced in human pituitary tumors 126
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations. 126
New insights in the pathogenesis of pituitary tumours 125
Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors 125
Salivary gland tissues and derived primary and metastatic neoplasms: unusual pitfalls in the work-up of sellar lesions. A systematic review 125
The genetics of pituitary adenomas 124
Cardiac effects of SR-Lanreotide, a slow-release somatostatin analog, in acromegalic patients 123
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients 122
A critical re-appraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas 122
Comparison of six-months therapy with octreotide versus lanreotide in acromegalic patients: a retrospective study 122
Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. 122
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells 122
A multivariable prediction model for pegvisomant dosing: Monotherapy and in combination with long-acting somatostatin analogues 122
Clinical and genetic features of familial pituitary adenomas 121
Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database 121
Macroprolactinomas as a cause of delayed puberty: a report of two cases and effects of medical therapy 120
Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature 120
Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients 120
Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions 120
Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas 120
Relationship between blood pressure and glucose tolerance in acromegaly 119
Influence of radiotherapy on long-term follow-up of clinically non-secreting pituitary adenomas 119
Acute effects of octreotide, cabergoline and a combination of both drugs on GH secretion in acromegalic patients 118
Effects of gonadal steroids on the growth of human pituitary adenomas in vitro 117
Expression of Epidermal Growth Factor in neoplastic pituitary cells: evidence for a role in corticotrophinoma cells 117
The prevalence of silent acromegaly in prolactinomas is very low 117
Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds. 116
The Role of Aryl Hydrocarbon Receptor (AHR) and AHR-Interacting Protein (AIP) in the Pathogenesis of Pituitary Adenomas 116
Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrine follow-up results 115
Beta-interferon, retinoids and tamoxifen as maintenance therapy in metastatic breast cancer. A pilot study 114
Il ruolo dell'endocrinologo nel trattamento delle lesioni della regione sellare 113
Familial pituitary adenomas. 112
Effect of 17β-estradiol, progesterone and tamoxifen on in vitro proliferation of human pituitary adenomas. Correlation with specific cellular receptors 111
Prevalence of hypertension in acromegalic patients: clinical measurement versus 24-hour ambulatory blood pressure monitoring 111
Sellar and parasellar lesions in the transition age: a retrospective Italian multi-centre study 110
De la génétique des adénomes hypophysaires 110
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal 109
Genetic susceptibility in pituitary adenomas: from pathogenesis to clinical implications 108
Familial pituitary adenomas: from clinical practice to basic research 108
Infusione sequenziale di GHRH 1-29NH2, LHRH e TRH per la valutazione della riserva ipofisaria: confronto con il Politest. 107
Prognostic Factors: Molecular Pathway – Tumour Suppressor Gene (MEN1) 107
Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics 106
Ageing and pituitary neuroendocrine tumours (PitNETs): from bench to bedside 105
Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly 105
HPLC determination of urinary catecholamines as a screening test for pheochromocytoma in a patient with medullary carcinoma of the thyroid. 103
Surgical treatment and clinical outcome of GH-secreting adenomas in elderly patients 103
Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques. 103
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects 103
Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution 102
Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion 101
Surgical treatment of pituitary tumours in the elderly: clinical outcome and long-term follow-up 101
The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas 101
Two-year follow-up of acromegalic patients treated with slow release Lanreotide (30 mg) 100
Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1 100
Pituitary adenomas in young patients: when should we consider a genetic predisposition? 98
Long-term follow-up results of postoperative radiation therapy for Cushing's disease 97
Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update 97
Clinical and Molecular Characteristics of Gonadotroph Pituitary Tumors According to the WHO Classification 97
Cellular receptors for sex steroids in human pituitary adenomas 96
Evaluation of the adequacy of Levothyroxine replacement therapy in patients with central hypothyroidism 96
Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene 96
Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure ? An audit of surgical results on a large series and a review of the literature 96
Visual improvement during octreotide therapy in a case of episellar meningioma 96
Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients. 94
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study. 93
Epidermal growth factor (EGF)- binding sites in human pituitary adenomas 92
Fenofibrate has differential effects on cell proliferation and GH secretion in GH3 cells 92
The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the aryl hydrocarbon receptor interacting protein (AIP) gene 90
Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion 90
Totale 12.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022431 0 0 0 0 36 7 5 44 37 7 33 262
2022/20231.879 136 112 74 173 163 215 2 116 792 5 64 27
2023/2024528 159 29 19 69 33 136 9 13 2 15 12 32
2024/20251.826 47 27 180 35 292 148 223 176 383 61 155 99
2025/20263.573 137 342 267 294 302 268 713 185 313 379 324 49
2026/20271.895 101 265 370 889 270 0 0 0 0 0 0 0
Totale 13.102